Trade ImmuCell - ICCC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.16 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.04 |
| Open | 4.03 |
| 1-Year Change | -20.2% |
| Day's Range | 4.01 - 4.05 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 4.04 | 0.00 | 0.00% | 4.04 | 4.09 | 3.94 |
| Jul 24, 2024 | 4.05 | -0.02 | -0.49% | 4.07 | 4.07 | 4.04 |
| Jul 23, 2024 | 4.14 | 0.06 | 1.47% | 4.08 | 4.14 | 4.04 |
| Jul 22, 2024 | 4.10 | -0.04 | -0.97% | 4.14 | 4.14 | 4.05 |
| Jul 19, 2024 | 4.14 | -0.05 | -1.19% | 4.19 | 4.19 | 4.07 |
| Jul 18, 2024 | 4.18 | 0.00 | 0.00% | 4.18 | 4.19 | 4.18 |
| Jul 17, 2024 | 4.23 | 0.05 | 1.20% | 4.18 | 4.23 | 4.18 |
| Jul 16, 2024 | 4.20 | 0.01 | 0.24% | 4.19 | 4.24 | 4.17 |
| Jul 15, 2024 | 4.23 | 0.05 | 1.20% | 4.18 | 4.23 | 4.14 |
| Jul 12, 2024 | 4.24 | 0.06 | 1.44% | 4.18 | 4.24 | 4.12 |
| Jul 11, 2024 | 4.18 | 0.00 | 0.00% | 4.18 | 4.26 | 4.13 |
| Jul 10, 2024 | 4.18 | 0.04 | 0.97% | 4.14 | 4.22 | 4.10 |
| Jul 9, 2024 | 4.14 | 0.00 | 0.00% | 4.14 | 4.16 | 4.14 |
| Jul 8, 2024 | 4.15 | 0.01 | 0.24% | 4.14 | 4.19 | 4.08 |
| Jul 5, 2024 | 4.19 | 0.00 | 0.00% | 4.19 | 4.19 | 4.17 |
| Jul 3, 2024 | 4.14 | -0.01 | -0.24% | 4.15 | 4.24 | 4.14 |
| Jul 2, 2024 | 4.09 | -0.37 | -8.30% | 4.46 | 4.46 | 4.09 |
| Jul 1, 2024 | 4.38 | -0.15 | -3.31% | 4.53 | 4.54 | 4.34 |
| Jun 28, 2024 | 4.69 | 0.40 | 9.32% | 4.29 | 4.72 | 4.23 |
| Jun 27, 2024 | 4.22 | -0.10 | -2.31% | 4.32 | 4.51 | 4.21 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ImmuCell Company profile
About ImmuCell Corporation
ImmuCell Corporation is an animal health company. The Company is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. It manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. It expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The Company is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ImmuCell Corporation revenues increased 19% to $13.8M. Net loss decreased 87% to $152K. Revenues reflect First Defense® product line segment increase of 44% to $9.5M, Other animal health segment increase of 83% to $186K, United States segment increase of 18% to $12.2M, Others segment increase of 28% to $1.6M.
Equity composition
Common Stock $.10 Par, 12/10, 8M auth., 3,261,148 issd., less 287,496 shs. in Treas. @ $635K. Insiders own 26.70%. PO 5/87, 966,000 Units (100 Common + 5 Warrants) @ $7/Unit by Stuart James. 7/90, 1-for-100 reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
56 Evergreen Drive
PORTLAND
MAINE 04103
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com